SPOP and prostate carcinoma: Our results showed that prostate cancer-derived SPOP mutants including Y87C, F102V, W131G, and F133L, which are located in its substrate-recognizing MATH domain, failed to bind to and promote HDAC6 degradation (Figure 5).